Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. 

Biotechnology

Sensorium Therapeutics

Dick Simon

Sherry Rais

Steve Haggarty

Pranav Tadi

Michael Placzek

Jerry Rosenbaum

Jeffrey Brown

Jacob Hooker

Alex Simon

The Leadership Team at Sensorium Therapeutics is responsible for steering the company's strategic vision and guiding its scientific and business operations. Comprised of co-founders, scientific leaders, and finance experts, this team leverages their collective expertise to drive the development of breakthrough psychoactive medicines, foster innovation through the Biodynamic Discovery Platform, and ensure the company's growth and success in improving mental health worldwide.

Leadership Team

Board Members and Directors

Research and Sciences

Leadership Team

About

Team members

Other teams at Sensorium Therapeutics

Board Members and Directors

Research and Sciences